Concept of Nanoconfinement Improves Sensitivity and Safety of a Life-saving Diagnostic Contrast Agent
The Yale-led research team found that when packaged in a nanoparticle, CT contrast agents, such as iodine, increased the absorption of X-rays.
- April 09, 2021
Welcome New Staff (April 2021)
- April 09, 2021Source: Dos Mundos
A new mural will be unveiled in the Northeast area of Kansas City, Missouri, to help educate and raise awareness about peripheral artery disease.
- April 07, 2021Source: The American Bazaar
Grant allows Yale researcher to develop automated tools for better heart healthcare.
- April 06, 2021Source: MedPage Today
Peripheral artery disease (PAD) patients with intermittent claudication could walk better after a year of regular home-based exercise at high intensity, researchers reported.
- April 06, 2021Source: American Heart Association News
A pandemic, protests and politics have highlighted the nation's long-standing, deep-seated racial issues and how they affect the health of millions of Americans.
- April 06, 2021Source: Northeast News
Medical researchers and artists are sharing an important message about vascular health with Northeast Kansas City through art.
- April 05, 2021Source: New Haven Register
Richard Gard, who has experienced the lingering health effects of COVID-19 after his hospitalization at Yale New Haven Hospital for COVID-19 in March 2020, is held by his wife, Evelyn, at their home.
- April 01, 2021
Yale researcher Rohan Khera, MD, MS, has received a K23 career development grant from the National Heart, Lung, and Blood Institute (NHLBI).
- March 30, 2021Source: Contagion
Intermediate-dose prophylactic anticoagulation did not improve mortality or venous or arterial thrombosis in patients with COVID-19 in the ICU compared with standard dosing, a new study found.